Cargando…

Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial

BACKGROUND: It has been suggested that vitamin D and its receptors involve in suppressing fibrogenic signaling in non-alcoholic fatty liver disease (NAFLD). However, the effect of vitamin D supplementation on fibrogenic factors has not been investigated in NAFLD individuals with steatohepatitis. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ebrahimpour-Koujan, Soraiya, Sohrabpour, Amir Ali, Foroughi, Farshad, Alvandi, Ehsan, Esmaillzadeh, Ahmad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398251/ https://www.ncbi.nlm.nih.gov/pubmed/30832722 http://dx.doi.org/10.1186/s13063-019-3241-7

Ejemplares similares

Effects of probiotics on salivary cytokines and immunoglobulines: a systematic review and meta-analysis on clinical trials
por: Ebrahimpour-Koujan, Soraiya, et al.
Publicado: (2020)

Association between Dietary Fat Intake and Odds of Gastro-esophageal Reflux Disorder (GERD) in Iranian Adults
por: Ebrahimpour-Koujan, Soraiya, et al.
Publicado: (2021)

A Population-Based Case-Control Study on Dietary Total Antioxidant Capacity in Relation to Breast Cancer in a Middle-Eastern Country
por: Ebrahimpour-Koujan, Soraiya, et al.
Publicado: (2022)

The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial
por: Ebrahimi-Mousavi, Sara, et al.
Publicado: (2022)

Association between healthy lifestyle score and breast cancer
por: Ghosn, Batoul, et al.
Publicado: (2020)

Adherence to low carbohydrate diet and prevalence of psychological disorders in adults
por: Ebrahimpour-Koujan, Soraiya, et al.
Publicado: (2019)

A combined healthy lifestyle score in relation to glioma: a case-control study
por: Ebrahimpour-Koujan, Soraiya, et al.
Publicado: (2022)

The effect of zinc supplementation on anthropometric measurements in healthy children over two years: a systematic review and meta-analysis
por: Monfared, Vahid, et al.
Publicado: (2023)

Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients
por: Jamali, Raika, et al.
Publicado: (2020)

Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial
por: Dashti, Fatemeh, et al.
Publicado: (2023)

The effect of vitamin D supplementation on blood sugar and different indices of insulin resistance in patients with non-alcoholic fatty liver disease (NAFLD)
por: Foroughi, Mehdi, et al.
Publicado: (2016)

The Association between Circulating Carotenoids and Risk of Breast Cancer: A Systematic Review and Dose–Response Meta-Analysis of Prospective Studies
por: Dehnavi, Maryam Karim, et al.
Publicado: (2023)

Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
por: Subramanian, Pallavi, et al.
Publicado: (2022)

Effect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver
por: Foroughi, Mahdi, et al.
Publicado: (2014)

Isolation of primary human liver cells from normal and nonalcoholic steatohepatitis livers
por: Liu, Xiao, et al.
Publicado: (2023)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases
por: Safaei, Akram, et al.
Publicado: (2016)

Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology
por: Akter, Sharmin
Publicado: (2022)

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2016)

Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease
por: Marmur, Joel, et al.
Publicado: (2018)

Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future
por: Barchetta, Ilaria, et al.
Publicado: (2017)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
por: Gallego-Durán, Rocío, et al.
Publicado: (2016)

LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
por: Ceccarelli, Sara, et al.
Publicado: (2015)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Iravani, Farzaneh, et al.
Publicado: (2018)

Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Ahsan, Farah, et al.
Publicado: (2020)

Using intestinal flora to distinguish non-alcoholic steatohepatitis from non-alcoholic fatty liver
por: Li, Chao, et al.
Publicado: (2020)

Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis
por: Ghandian, Sina, et al.
Publicado: (2022)

Preventive Effect of Glycyrrhiza Glabra Extract on Oral Mucositis in Patients Under Head and Neck Radiotherapy: A Randomized Clinical Trial
por: Najafi, Shamsolmolok, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
por: Tacke, Frank, et al.
Publicado: (2021)

Can Nutritional Supplements Benefit Patients With Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease?
por: Baradeiya, Ahmed M, et al.
Publicado: (2023)

Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
por: Yu, Rui, et al.
Publicado: (2018)

The fibrogenic process and the unleashing of acute-on-chronic liver failure
por: López-Sánchez, Guillermo Nahúm, et al.
Publicado: (2020)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
por: Daher, Saleh, et al.
Publicado: (2018)

Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
por: Kim, Jeong Woo, et al.
Publicado: (2020)

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
por: Hattori, Sachiko, et al.
Publicado: (2021)

Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis
por: Ma, Mengyao, et al.
Publicado: (2021)

Establishment of Orthotopic Liver Tumors by Surgical Intrahepatic Tumor Injection in Mice with Underlying Non-Alcoholic Fatty Liver Disease
por: Brown, Zachary J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8b3ic1915rvgaddanp2frulolb